News & Events from the industry and our members

Member Profile: Faron Pharmaceuticals – A Finnish Innovation at the Forefront of Immunotherapy

Korvaa consortium unveils world-first concept shoe formed from three revolutionary biomaterial technologies

Member Introduction: Bonalive – Bioactive Technology as a Sustainable Treatment Against Antibiotic Resistance

Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio

Member Introduction: StemSight - A New Treatment for Corneal Blindness 

Made by Cells - Biotech Forum - April 10th 2025

Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline

Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A